Business modelsB2B

Products 11 to 20 of 162

Biotech components: Bacteria
Business models: B2B
Country of production: England
Country of distribution: England
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/08/30 11:49 (5 years ago)
Known funding amount: N/A
Funding types: Government
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): University + Research Institution
Product categories: Plant
Production process: Open Release
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Biotech components: Enzyme
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/08/30 11:49 (5 years ago)
Known funding amount: 6,438,793 USD
Funding types: Government
Industry: Science
Market status: Under Development
Organization type(s): Private Company
Product categories: Research
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Platform
Bacterial Cellulose produced by Microorganisms by Chinese Academy of Sciences
Biotech components: Bacteria + Enzyme + Microbe
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/02/10 09:55 (4 years ago)
Date last modified: 2020/02/10 09:55 (4 years ago)
Known funding amount: N/A
Funding types: Government + Research Institution + University
Industry: Industrial + Medical + Science
Market status: Early Stage Concept
Organization type(s): Research Institution + University
Product categories: N/A
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Platform
Bacterial Live Wires by Berkeley Lab
Biotech components: Bacteria
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/08/30 11:49 (5 years ago)
Known funding amount: N/A
Funding types: Research Institution
Industry: Science
Market status: Early Stage Concept
Organization type(s): University + Research Institution
Product categories: Research
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Bacterial toxin promoting tissue healing by Friedrich Schiller University Jena
Biotech components: Bacteria
Business models: B2B + B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:39 (3 years ago)
Date last modified: 2020/12/18 14:39 (3 years ago)
Known funding amount: N/A
Funding types: University
Industry: Medical
Market status: Early Stage Concept
Organization type(s): University
Product categories: Medical Treatment + Medicine
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: N/A
Biotech components: Molecule
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/08/30 11:49 (5 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Bio-based 1,4 Butanediol by BioAmber, Inc.
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: Canada
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/11/08 14:28 (5 years ago)
Known funding amount: 3,000,000 CAN
Funding types: Debtor-in-possession financing + Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: NASEM Database
Trading symbol: BIOA (NYSE)
Value chain stage: Input
Bio-based Disodium Succinate by BioAmber, Inc.
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: Canada
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/11/08 14:28 (5 years ago)
Known funding amount: 3,000,000 CAN
Funding types: Debtor-in-possession financing + Shareholder Investment
Industry: Food & Agriculture
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Additive
Production process: Closed Production
Source: NASEM Database
Trading symbol: BIOA (NYSE)
Value chain stage: Input
Bio-based Drop-in Acrylic Acid by GC Innovation America + Myriant
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/09/13 15:23 (5 years ago)
Known funding amount: 110,000,000 USD
Funding types: Government + Venture Capital
Industry: Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Bio-based Polybutylene Succinate by GC Innovation America + Myriant
Biotech components: Molecule
Business models: B2B
Country of production: USA
Country of distribution: Japan + China + Korea + USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/11/09 16:26 (5 years ago)
Known funding amount: 110,000,000 USD
Funding types: Government + Venture Capital
Industry: Industrial
Market status: On the market
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input